Ledger.Open graph →
SEC Form D · filed July 6, 2020

Santi Therapeutics, Inc

Offering
$14.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Milind Deshpande · Boston, MAExec · DirectorJoshua Resnick · Boston, MADirectorAndrew Levin · Boston, MADirectorRavikiran Thummalapenta · CENTERVILLE, VADirectorShawn M. Stasko · Lexington, KYExec · DirectorTom B. Orradre · Newport Beach, CADirectorNathaniel Brooks Horwitz · Boston, MADirectorThomas D. Estes · Atlanta, GADirectorJay W. Trulove · Berryville, ARDirectorMenno E. Ellis · Rock Hill, SCExec · DirectorNathaniel Brooks Horwitz · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗